Giant Cell Arteritis
- Boot Camp

- Oct 15, 2023
- 0 min read
History Taking
Chief Complaint:
New onset headaches, usually on one side of the head
Jaw pain when chewing
Visual disturbances or sudden vision loss in one eye
Fever, fatigue, weight loss, and general discomfort
History of Presenting Complaint:
Severe, localized headaches that started a few weeks or months ago
The pain might worsen with scalp tenderness, brushing hair or wearing a hat
Recent issues with vision, such as double vision or transient vision loss (amaurosis fugax)
Experiencing pain in the tongue or throat, sometimes while eating
Reports of generalized malaise or flu-like symptoms
System Review:
Neurological: Visual disturbances, including partial or complete loss of vision, double vision
Musculoskeletal: Polymyalgia rheumatica symptoms, such as aches, pain and stiffness in the shoulders, neck, or hips
Cardiovascular: Potential claudication symptoms due to arteritis affecting other large arteries
Past Medical History:
History of polymyalgia rheumatica, if present, can strongly indicate Giant cell arteritis
Any auto-immune or vasculitis conditions
Previous similar episodes with resolution
Drug History:
Recent use of corticosteroids which may mask some symptoms
Non-steroidal anti-inflammatory drugs (NSAIDs) for headache or musculoskeletal pain
Personal History:
Typically, GCA occurs in individuals over 50 years of age
Females are more likely to get it than males
Northern European (particularly Scandinavian) ancestry is a risk factor
High body mass index in early adulthood may be a risk factor
Social History:
Smoking history: Some studies suggest an increased risk with smoking
Alcohol: Moderate alcohol consumption may have a protective effect
Physical Examination
General Examination:
Palpation of the temporal artery may reveal thickening, tenderness, and reduced pulsation
Signs of weight loss or general ill health
Examination of the Hands and Arms:
Absent or diminished pulses in the arm due to arteritis affecting the subclavian arteries
Examination of the Face:
Evidence of ptosis or ophthalmoplegia due to cranial nerve involvement
Fundoscopy may reveal pallor of the optic disc in case of anterior ischemic optic neuropathy, a complication of GCA
Examination of the Neck:
Carotid arteries may show reduced pulsation if affected
Cardiac Examination:
Bruits may be heard over the subclavian arteries or the carotid arteries if they are involved
Some patients may exhibit signs of aortic regurgitation due to large vessel involvement
Neurological Examination:
Visual field testing may reveal defects
Check for signs of stroke or transient ischemic attacks due to involvement of cerebral arteries
Investigations
Laboratory Investigations:
Full blood count: may show normocytic normochromic anemia or reactive thrombocytosis
Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP): Both are markers of inflammation and are typically significantly elevated in GCA
Liver function tests: Alkaline phosphatase can be elevated in case of large vessel GCA
Autoimmune screen: to rule out other vasculitis or connective tissue diseases
Imaging:
Ultrasound of the temporal and axillary arteries: to identify a 'halo sign' which is an echo-poor area around the temporal artery
MRI, CT, or PET scan: may be needed to identify large vessel involvement
Invasive:
Temporal artery biopsy: the gold standard for diagnosis, showing characteristic granulomatous inflammation with multinucleated giant cells, although it can be negative in up to 15% of cases
Angiography: can be useful to confirm involvement of large arteries such as the aorta or subclavian arteries
Other Tests:
Visual field testing: to identify any defects due to optic nerve ischemia
Ophthalmoscopy: to identify signs of retinal or optic nerve ischemia
Management
General Management:
Patient education: Explanation about the condition, its implications, the need for urgent treatment and long-term follow-up
Medical:
High-dose corticosteroids: Immediate treatment with oral prednisolone or intravenous methylprednisolone to prevent vision loss
Steroid-sparing agents: Methotrexate or azathioprine can be used for patients who have recurrent or refractory disease or those who experience significant side effects from corticosteroids
Antiplatelet or anticoagulant therapy: Low-dose aspirin may be recommended to reduce the risk of stroke
Surgical:
Temporal artery biopsy: Invasive but can confirm diagnosis and may be performed after starting corticosteroid therapy
Rarely, vascular surgery may be required in cases with significant large vessel involvement
Other:
Regular follow-up: Monitoring for disease activity, side effects of treatment, and development of associated conditions (like polymyalgia rheumatica)
Bone protection: Patients on long-term corticosteroids should be offered bone protection, such as bisphosphonates and calcium/vitamin D supplements
Vaccinations: Annual influenza and regular pneumococcal vaccines due to increased susceptibility from long-term corticosteroid use
Lifestyle modifications: Encourage smoking cessation and healthy diet, as patients are at increased risk of cardiovascular disease.
